申请人:IMPERIAL CHEMICAL INDUSTRIES PLC
公开号:EP0318225A2
公开(公告)日:1989-05-31
The invention relates to a quinoline of the formula:-
wherein each of R¹ and R², which may be the same or different, is hydrogen, halogeno, hydroxy, cyano, carbamoyl, nitro or amino, alkyl, alkoxy, alkylthio, alkylamino, dialkylamino or alkanoylamino each of up to 4 carbon atoms, or substituted alkyl or alkoxy each of up to 3 carbon atoms, provided that both R¹ and R² are not hydrogen;
the quinoline ring may bear further substituents;
R³ is hydrogen or alkyl of up to 4 carbon atoms;
R⁴ is hydrogen, alkyl, alkenyl or alkynyl each of up to 4 carbon atoms or substituted alkyl of up to 3 carbon atoms;
Ar is phenylene, naphthylene or heterocyclene which is unsubstituted or which bears one or more substituents;
R⁵ is such that R⁵-NH₂ is an amino acid;
or a pharmaceutically-acceptable salt or ester thereof.
The compounds possess anti-tumour activity.
本发明涉及一种式如下的
喹啉
其中R¹和R²可以相同或不同,各自为
氢、卤素、羟基、
氰基、
氨基甲酰基、硝基或
氨基、烷基、烷
氧基、烷
硫基、烷基
氨基、二烷基
氨基或烷酰
氨基,各自最多为4个
碳原子,或取代的烷基或烷
氧基,各自最多为3个
碳原子,条件是R¹和R²都不是
氢;
喹啉环可带有其他取代基;
R³ 是
氢或最多 4 个
碳原子的烷基;
R⁴ 是
氢、各含最多 4 个
碳原子的烷基、
烯基或炔基或含最多 3 个
碳原子的取代烷基;
Ar 是未取代的
苯基、
萘基或杂环基,或带有一个或多个取代基;
R⁵ 是 R⁵-NH₂ 是
氨基酸;
或其药学上可接受的盐或
酯。
这些化合物具有抗肿瘤活性。